Summary
- Current Price
- As of today, BLRX price is $3.16, up +3.27% in the most recent trading session on
- Current Price All-Time High
- BLRX price is currently -99.92% below its historical high of $4,122.00 set on
- Market Cap
- BLRX current market cap is $14M, up +4.40% over the past 365 days
- PE Ratio
- BLRX PE ratio is unknown
- Revenue
- BLRX current annual revenue is $1.19M, down -95.91% year-over-year
- Next Earnings
- The next earnings release for BLRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioLineRx Ltd. |
| Ticker | NASDAQ: BLRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | biolinerx.com |
| Employees | 28 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.16 | ||
| Price, 1D Change | +3.27% | |
| $14M | ||
| - | ||
| - | ||
| 0.76 | ||
| $1M | ||
| Revenue, 1Y Change | -95.91% | |
| -$0.29 | ||
| EPS, 1Y Change | +93.75% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:40 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.29 | ||
| EPS Estimate | N/A | -$1.09 |
| EPS Est. Change | N/A | -275.47% |
| $1.19M | ||
| Revenue Estimate | N/A | $1.49M |
| Revenue Est. Change | N/A | +25.61% |
| $3.16 | ||
| Price Target | - | $17.50 |
| Price Tgt. Change | - | +453.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.20 | -$4.64 | -45.06% | |
| -$0.68 | -$0.29 | +57.31% | |
| -$1.09 | N/A | -275.47% | |
| -$0.67 | N/A | -130.80% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $24.91M | $29.08M | +16.72% | |
| $1.48M | $1.19M | -19.53% | |
| $1.49M | N/A | +25.61% | |
| $2.01M | N/A | +68.87% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -13.66% | ||
| -94.73% | ||
| +4.40% | ||
| -84.60% | ||
| -95.91% | ||
| +100.00% | ||
| +93.75% | ||
| +39.97% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.16 | ||
| $3.16 | ||
| SMA 200 vs Price | +0.15% | |
| $2.60 | ||
| SMA 50 vs Price | -17.72% | |
| 0.76 | ||
| $0.22 | ||
| 57.62 | ||
| 74.60% | ||
| 79.71% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.19M | ||
| -$0.29 | ||
| $430.40K | ||
| 36.19% | ||
| -$10.37M | ||
| -871.75% | ||
| -$2.04M | ||
| -171.69% | ||
| -$9.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.56 | ||
| 1.95 | ||
| 1.78 | ||
| - | ||
| 2 | ||
| -13.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 11.97 | ||
| 0.78 | ||
| -0.36 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.20M | ||
| $20.88M | ||
| $40.90M | ||
| $23.68M | ||
| $17.56M | ||
| $12.12M | ||
| $10.15M | ||
| $4.71M | ||
| $3.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.37M | ||
| $10.80M | ||
| $759.00K | ||
| $0.00 | ||
| $527.10K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$8.14M | ||
| -$8.61M | ||
| $8.95M | ||
| $27.20K | ||
| -$8.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Jones Trading | → | |
| HC Wainwright & Co. | → | |
| Jones Trading | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with BLRX
FAQ
What is the ticker symbol for BioLineRx Ltd.?
The ticker symbol for BioLineRx Ltd. is NASDAQ:BLRX
Does BioLineRx Ltd. pay dividends?
No, BioLineRx Ltd. does not pay dividends
What sector is BioLineRx Ltd. in?
BioLineRx Ltd. is in the Healthcare sector
What industry is BioLineRx Ltd. in?
BioLineRx Ltd. is in the Biotechnology industry
What country is BioLineRx Ltd. based in?
BioLineRx Ltd. is headquartered in Israel
When did BioLineRx Ltd. go public?
BioLineRx Ltd. initial public offering (IPO) was on July 27, 2011
Is BioLineRx Ltd. in the S&P 500?
No, BioLineRx Ltd. is not included in the S&P 500 index
Is BioLineRx Ltd. in the NASDAQ 100?
No, BioLineRx Ltd. is not included in the NASDAQ 100 index
Is BioLineRx Ltd. in the Dow Jones?
No, BioLineRx Ltd. is not included in the Dow Jones index
When was BioLineRx Ltd. last earnings report?
BioLineRx Ltd.'s most recent earnings report was on March 23, 2026
When does BioLineRx Ltd. report earnings?
The next expected earnings date for BioLineRx Ltd. is May 27, 2026
Data Sources & References
- BLRX Official Website www.biolinerx.com
- BLRX Profile on Yahoo Finance finance.yahoo.com/quote/BLRX
- BLRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/blrx